These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

699 related articles for article (PubMed ID: 16951005)

  • 21. Phaeochromocytomas and sympathetic paragangliomas.
    Petri BJ; van Eijck CH; de Herder WW; Wagner A; de Krijger RR
    Br J Surg; 2009 Dec; 96(12):1381-92. PubMed ID: 19918850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perioperative risk factors, morbidity, and outcome of 145 patients during phaeochromocytoma resection.
    Kazic MR; Zivaljevic VR; Milan ZB; Paunovic IR
    Acta Chir Belg; 2011; 111(4):223-7. PubMed ID: 21954738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Germline SDHB mutations are common in patients with apparently sporadic sympathetic paragangliomas.
    Klein RD; Jin L; Rumilla K; Young WF; Lloyd RV
    Diagn Mol Pathol; 2008 Jun; 17(2):94-100. PubMed ID: 18382370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Results of surgical treatment of pheochromocytoma at the Institute of Endocrinology of the Clinical Center of Serbia in Belgrade].
    Janković R; Diklić A; Paunović I; Krgović K; Hivaljević V; Todorović-Kazić M; Havelka M; Tatić S; Dimitrijević N
    Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():38-42. PubMed ID: 12584996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paragangliomas in patients with mutations of the SDHD gene.
    Boedeker CC; Neumann HP; Ridder GJ; Maier W; Schipper J
    Otolaryngol Head Neck Surg; 2005 Mar; 132(3):467-70. PubMed ID: 15746863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Presentation and Treatment Outcomes of Children and Adolescents With Pheochromocytoma and Paraganglioma in a Single Center in Korea.
    Park H; Kim MS; Lee J; Kim JH; Jeong BC; Lee S; Lee SK; Cho SY; Jin DK
    Front Endocrinol (Lausanne); 2020; 11():610746. PubMed ID: 33584544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term postoperative follow-up in patients with apparently benign pheochromocytoma and paraganglioma.
    Amar L; Fassnacht M; Gimenez-Roqueplo AP; Januszewicz A; Prejbisz A; Timmers H; Plouin PF
    Horm Metab Res; 2012 May; 44(5):385-9. PubMed ID: 22351478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimated risk of pheochromocytoma recurrence after adrenal-sparing surgery in patients with multiple endocrine neoplasia type 2A.
    Asari R; Scheuba C; Kaczirek K; Niederle B
    Arch Surg; 2006 Dec; 141(12):1199-205; discussion 1205. PubMed ID: 17178962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose iodine-131 metaiodobenzylguanidine therapy for patients with malignant pheochromocytoma and paraganglioma: single center experience.
    Shilkrut M; Bar-Deroma R; Bar-Sela G; Berniger A; Kuten A
    Am J Clin Oncol; 2010 Feb; 33(1):79-82. PubMed ID: 19704370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disentangling of Malignancy from Benign Pheochromocytomas/Paragangliomas.
    Kim KY; Kim JH; Hong AR; Seong MW; Lee KE; Kim SJ; Kim SW; Shin CS; Kim SY
    PLoS One; 2016; 11(12):e0168413. PubMed ID: 27992508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel candidate region linked to development of both pheochromocytoma and head/neck paraganglioma.
    Cascón A; Ruiz-Llorente S; Rodríguez-Perales S; Honrado E; Martínez-Ramírez A; Letón R; Montero-Conde C; Benítez J; Dopazo J; Cigudosa JC; Robledo M
    Genes Chromosomes Cancer; 2005 Mar; 42(3):260-8. PubMed ID: 15609347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of large versus small pheochromocytomas: operative approaches and patient outcomes.
    Wilhelm SM; Prinz RA; Barbu AM; Onders RP; Solorzano CC
    Surgery; 2006 Oct; 140(4):553-9; discussion 559-60. PubMed ID: 17011902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response after surgical resection of metastatic pheochromocytoma and paraganglioma: can postoperative biochemical remission be predicted?
    Ellis RJ; Patel D; Prodanov T; Sadowski S; Nilubol N; Adams K; Steinberg SM; Pacak K; Kebebew E
    J Am Coll Surg; 2013 Sep; 217(3):489-96. PubMed ID: 23891076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pheochromocytoma: an update on genetics and management.
    Karagiannis A; Mikhailidis DP; Athyros VG; Harsoulis F
    Endocr Relat Cancer; 2007 Dec; 14(4):935-56. PubMed ID: 18045948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perioperative management of pheochromocytoma/paraganglioma: is there a state of the art?
    Mannelli M; Dralle H; Lenders JW
    Horm Metab Res; 2012 May; 44(5):373-8. PubMed ID: 22517559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial pheochromocytoma.
    Bissada MA; Safwat AS; Seyam RM; Al Sobhi S; Hanash KA; Bissada NK
    Urol Oncol; 2008; 26(4):361-3. PubMed ID: 18367101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in urinary total metanephrine excretion in recurrent and malignant pheochromocytomas and secreting paragangliomas.
    Amar L; Peyrard S; Rossignol P; Zinzindohoue F; Gimenez-Roqueplo AP; Plouin PF
    Ann N Y Acad Sci; 2006 Aug; 1073():383-91. PubMed ID: 17102107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of pheochromocytomas and abdominal and pelvic paragangliomas with head and neck paragangliomas.
    Al-Harthy M; Al-Harthy S; Al-Otieschan A; Velagapudi S; Alzahrani AS
    Endocr Pract; 2009 Apr; 15(3):194-202. PubMed ID: 19364686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uncommon clinical presentations of pheochromocytoma and paraganglioma in two different patients affected by two distinct novel VHL germline mutations.
    Ercolino T; Becherini L; Valeri A; Maiello M; Gaglianò MS; Parenti G; Ramazzotti M; Piscitelli E; Simi L; Pinzani P; Nesi G; Degl'Innocenti D; Console N; Bergamini C; Mannelli M
    Clin Endocrinol (Oxf); 2008 May; 68(5):762-8. PubMed ID: 18031321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presymptomatic genetic testing in minors at risk of paraganglioma and pheochromocytoma: our experience of oncogenetic multidisciplinary consultation.
    Lahlou-Laforêt K; Consoli SM; Jeunemaitre X; Gimenez-Roqueplo AP
    Horm Metab Res; 2012 May; 44(5):354-8. PubMed ID: 22517555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.